Table 1. Synthetic peptides used in this study.
No. | Position | Sequence |
---|---|---|
1 | 1–18 | MPNNNGKQQKKKKGNGQP |
2 | 8–25 | QQKKKKGNGQPVNQLCQM |
3 | 15–32 | NGQPVNQLCQMLGKIIAQ |
4 | 22–39 | LCQMLGKIIAQQNQSRGK |
5 | 29–45 | IIAQQNQSRGKGPGKKN |
6 | 35–52 | QSRGKGPGKKNRKKNPEK |
7 | 42–59 | GKKNRKKNPEKPHFPLAT |
8 | 49–66 | NPEKPHFPLATEDDVRHH |
9 | 56–73 | PLATEDDVRHHFTPSERQ |
10 | 63–80 | VRHHFTPSERQLCLSSIQ |
11 | 70–87 | SERQLCLSSIQTAFNQGA |
12 | 77–94 | SSIQTAFNQGAGTCALSD |
13 | 84–101 | NQGAGTCALSDSGRISYT |
14 | 91–108 | ALSDSGRISYTVEFSLPT |
15 | 98–115 | ISYTVEFSLPTQHTVRLI |
16 | 105–123 | SLPTQHTVRLIRATASPSA |
3m | 15–32 | DGQPVNQLCQMLGKIIAQ |
7m | 42–59 | GKKNKKKNPEKPHFPLAT |
12m | 77–94 | SSIQTAFNQGAGTCTLSD |